We are live on
!
Find out more
ARC
Absolute Return Capital Portfolio holdings
AUM
$1.57B
1-Year Est. Return
6.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
-6.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.1B
AUM Growth
+$1.89B
(+26%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
12.63%
Holding
786
New
160
Increased
244
Reduced
271
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$145M |
| 2 |
Procter & Gamble
PG
|
+$121M |
| 3 |
Chevron
CVX
|
+$104M |
| 4 |
Apple
AAPL
|
+$95.7M |
| 5 |
Microsoft
MSFT
|
+$74.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$52.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$50.3M |
| 3 |
Pfizer
PFE
|
+$42.9M |
| 4 |
CNX Resources
CNX
|
+$42.5M |
| 5 |
CVS Health
CVS
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.5% |
| 2 | Energy | 14.11% |
| 3 | Healthcare | 12.44% |
| 4 | Technology | 10.58% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$605B
| $181M | 1.99% |
1,785,966
+1,563,757
| +704% | +$145M |
|
|
2
Procter & Gamble
PG
$353B
| $157M | 1.73% |
1,931,637
+1,479,643
| +327% | +$121M |
|
|
3
Chevron
CVX
$366B
| $146M | 1.61% |
1,169,883
+863,633
| +282% | +$104M |
|
4
Walmart Inc
WMT
$915B
| $120M | 1.32% |
4,582,548
+2,825,016
| +161% | +$73M |
|
5
Norfolk Southern
NSC
$75.9B
| $104M | 1.14% |
1,115,520
+114,337
| +11% | +$9.81M |
|
|
6
Apple
AAPL
$4.89T
| $102M | 1.12% |
+5,068,168
| New | +$95.7M |
|
7
Caterpillar
CAT
$404B
| $86.2M | 0.95% |
949,566
+481,986
| +103% | +$41.2M |
|
8
GE Aerospace
GE
$361B
| $84.5M | 0.93% |
629,094
+15,699
| +3% | +$1.98M |
|
9
Abbott
ABT
$172B
| $84.5M | 0.93% |
2,203,672
+317,783
| +17% | +$11.7M |
|
|
RTN
10
DELISTED
Raytheon Company
RTN
| $83.7M | 0.92% |
923,313
-119,554
| -11% | -$9.98M |
|
11
Marathon Petroleum
MPC
$89.3B
| $81.3M | 0.89% |
1,772,088
+895,272
| +102% | +$34.4M |
|
12
Northrop Grumman
NOC
$73.7B
| $79.1M | 0.87% |
690,302
-175,149
| -20% | -$18.8M |
|
|
13
Microsoft
MSFT
$2.98T
| $77.1M | 0.85% |
+2,060,096
| New | +$74.8M |
|
14
Elevance Health
ELV
$80.9B
| $76.1M | 0.84% |
824,143
+71,715
| +10% | +$6.37M |
|
15
Cleveland-Cliffs
CLF
$5.44B
| $70.7M | 0.78% |
2,697,165
+698,179
| +35% | +$17.2M |
|
16
Alphabet (Google) Class C
GOOG
$4.32T
| $70M | 0.77% |
2,508,487
+2,002,437
| +396% | +$50.6M |
|
17
Humana
HUM
$46.4B
| $69.6M | 0.77% |
674,545
+6,384
| +1% | +$625K |
|
18
Deere & Co
DE
$162B
| $67.6M | 0.74% |
740,707
+272,196
| +58% | +$23M |
|
19
Oracle
ORCL
$358B
| $66.3M | 0.73% |
1,733,970
+779,201
| +82% | +$26.8M |
|
20
Phillips 66
PSX
$80.7B
| $64.9M | 0.71% |
841,533
+630,150
| +298% | +$42M |
|
21
CSX Corp
CSX
$94.6B
| $64.4M | 0.71% |
6,710,670
+1,251,957
| +23% | +$11.2M |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $63.9M | 0.7% |
931,743
+207,516
| +29% | +$13.5M |
|
23
CF Industries
CF
$18.2B
| $63.3M | 0.7% |
1,357,370
-14,415
| -1% | -$630K |
|
24
Lockheed Martin
LMT
$118B
| $63.2M | 0.7% |
425,440
-42,867
| -9% | -$5.82M |
|
25
Helmerich & Payne
HP
$3.34B
| $61.2M | 0.67% |
727,394
+32,817
| +5% | +$2.55M |
|
Similar funds
OA
MCC
NM
AH
TRV
GHF
CWA
RI
Absolute Return Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Absolute Return Capital held 786 positions worth $9.1B, up 26% from $7.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Absolute Return Capital deployed $1.21B of net new capital in Q4 2013, opening 160 new positions and adding to 244 existing holdings. Its largest new stake was Apple: 5,068,168 shares worth $102M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $52.3M trimmed.
- Absolute Return Capital's largest Q4 2013 buy was Apple: 5,068,168 shares worth $102M.
- Absolute Return Capital added most to ExxonMobil in Q4 2013, an estimated $145M increase.
- Absolute Return Capital's biggest Q4 2013 reduction was Amgen, cutting an estimated $52.3M.
- Absolute Return Capital fully exited Johnson & Johnson in Q4 2013, selling an estimated $50.3M.
- Absolute Return Capital's ten largest holdings make up 13% of its $9.1B portfolio in Q4 2013.
- Absolute Return Capital opened 160 new positions and closed 99 in Q4 2013.
- Absolute Return Capital's portfolio value rose 26% quarter-over-quarter to $9.1B.
Based on Absolute Return Capital's 13F filing for Q4 2013, filed 10 Feb 2014.